Quantcast

Heraeus Medical GMBH alleges Indiana companies unlawfully used trade secrets

PENNSYLVANIA RECORD

Sunday, December 22, 2024

Heraeus Medical GMBH alleges Indiana companies unlawfully used trade secrets

Shutterstock 376319674

shutterstock.com

PHILADELPHIA – A German company alleges two Indiana companies wrongfully used its trade secrets to develop a product.

Heraeus Medical GMBH filed a complaint on Dec. 7 in the U.S. District Court for the Eastern District of Pennsylvania against Zimmer Biomet Holdings Inc. and Biomet Inc. alleging violation of the Pennsylvania Uniform Trade Secrets Act.

According to the complaint, the plaintiff produces and develops bone cement and the defendants are competitors.

The plaintiff holds Zimmer Biomet Holdings Inc. and Biomet Inc. responsible because the defendants allegedly developed two copolymers, R262 and R263, which were developed using plaintiff's misappropriated trade secrets.

The plaintiff requests a trial by jury and seeks enjoin the defendants; direct the defendants to immediately return all plaintiff's property; disgorge all economic benefit obtained using copolymers; actual, compensatory and punitive damages; interest; court costs and any further relief the court grants. 

It is represented by Samuel W. Silver and John R. Timmer of Schnader Harrison Segal & Lewis LLP in Philadelphia; Matthew Wolf and John Nilsson of Arnold & Porter Kaye Scholer LLP in Washington, D.C.; and David Caine of Arnold & Porter Kaye Scholer LLP in Palo Alto, California.

U.S. District Court for the Eastern District of Pennsylvania case number 2:17-cv-05482-CMR

More News